Atypical Diabetes has been a focus of our research at the Kovler Diabetes Center since the 1980s.
Our Atypical Diabetes team is made up of internationally-recognized diabetes investigators with expertise in the pathophysiology and genetics of diabetes. We believe that identifying and studying rare and atypical forms of diabetes will lead to greater insights into the pathways of the more common forms, type 1 and type 2 diabetes.
Learn more about our collaborators.
Our research areas include:
-
- Monogenic Diabetes
- Wolfram Syndrome
- Lipodystrophies
- Insulin resistance syndromes
- Atypical autoimmune type 1 diabetes
We partner with diabetes experts from around the world to study rare and atypical diabetes. Our collaborators include:
- Massachusetts General Hospital, Harvard University, and the Broad Institute | Learn more about diabetes research at MGH
- Vanderbilt University | Learn more about diabetes research at Vanderbilt
- Columbia University | Learn more about diabetes research at Columbia
- University of Maryland | Learn more about the University of Maryland’s Monogenic Diabetes Research and Advocacy Project
- Geisinger Health System | Learn more about research at Geisinger
- University of North Carolina | Learn more about diabetes research at UNC
- University of Michigan | Learn more about lipodystrophy research at the University of Michigan
- Washington University in St. Louis | Learn more about Wolfram Syndrome research at WashU
- University of Colorado Denver | Learn more about diabetes research at UC-Denver
- University of Washington | Learn more about diabetes research at UW
- University of California San Francisco | Learn more about diabetes research at UCSF
- Emory University | Learn more about diabetes research at Emory
- University of Texas Health Science Center at Houston | Learn more about research at UTHealth
- Exeter University | Learn more about monogenic diabetes at the University of Exeter
